Literature DB >> 2515964

Hyperventilation and ergonovine tests in Prinzmetal's variant angina: comparative sensitivity and relation with the activity of the disease.

M Previtali1, D Ardissino, C Storti, R D Chimienti, J A Salerno.   

Abstract

Hyperventilation (HV) and ergonovine (E) tests were carried out in a group of 32 patients with variant angina to compare their sensitivity and to correlate the results with the activity of the disease. The HV test was positive in 84% of the patients and E in 94% of them; the percentage of positive responses to HV was similar to that to E (96% vs 100%) in the patients with daily attacks, while it was lower (55% vs 77%) in those with sporadic attacks. All 27 patients with a positive HV also had a positive response to E, while of the five patients with a negative HV, two also had a negative response to E and the other three had a positive E at a higher dose than that of the patients with daily attacks. The incidence of chest pain and of ST-segment elevation or depression or T-wave positivization was similar during the two tests; however, spontaneous remission of ischaemia was more frequent after HV than after E and ventricular arrhythmias less frequent during the HV test. At the onset of myocardial ischaemia pH was significantly higher compared with basal values (7.51 +/- 0.07 vs 7.38 +/- 0.05, P less than 0.001), while double product was not significantly different compared with basal (10.0 +/- 2.4 vs 9.2 +/- 2.1).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2515964     DOI: 10.1093/eurheartj/10.suppl_f.101

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  1 in total

1.  Long-term outcomes of a Caucasian cohort presenting with acute coronary syndrome and/or out-of-hospital cardiac arrest caused by coronary spasm.

Authors:  W Vlastra; M Piek; M A van Lavieren; M E J C Hassell; B E Claessen; G W Wijntjens; T P van de Hoef; K D Sjauw; M A Beijk; R Delewi; J J Piek
Journal:  Neth Heart J       Date:  2018-01       Impact factor: 2.380

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.